Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Asset Utilization Ratio (2021 - 2025)

Krystal Biotech's Asset Utilization Ratio history spans 4 years, with the latest figure at 0.3 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 6.06% year-over-year to 0.3; the TTM value through Dec 2025 reached 0.3, up 6.06%, while the annual FY2025 figure was 0.33, 5.05% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.3 at Krystal Biotech, down from 0.31 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.32 in Q2 2025 and bottomed at 0.0 in Q4 2021.
  • The 4-year median for Asset Utilization Ratio is 0.25 (2024), against an average of 0.2.
  • The largest annual shift saw Asset Utilization Ratio skyrocketed 2090.49% in 2024 before it increased 6.06% in 2025.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.0 in 2021, then surged by 2375.76% to 0.06 in 2023, then skyrocketed by 352.26% to 0.29 in 2024, then grew by 6.06% to 0.3 in 2025.
  • Per Business Quant, the three most recent readings for KRYS's Asset Utilization Ratio are 0.3 (Q4 2025), 0.31 (Q3 2025), and 0.32 (Q2 2025).